About BioLight
BioLight is a company based in Tel Aviv (Israel) founded in 2005.. The company has 4 employees as of December 31, 2024. BioLight operates in a competitive market with competitors including Retinai Medical, Toku Eyes, Big Vision, TearLab and Pr3vent, among others.
- Headquarter Tel Aviv, Israel
- Employees 4 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biolight Life Sciences Ltd.
-
Annual Revenue
$60.06 K (USD)247.62as on Dec 31, 2024
-
Net Profit
$-1.96 M (USD)8.98as on Dec 31, 2024
-
EBITDA
$-2.61 M (USD)2.18as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioLight
BioLight is a publicly listed company on the TASE with ticker symbol BOLT in Israel, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Leadership Team
2 people
Dr. Team
1 people
Software Development Team
1 people
Researcher Team
1 people
Unlock access to complete
Funding Insights of BioLight
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by BioLight
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioLight
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biolight Comparisons
Competitors of BioLight
BioLight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Retinai Medical, Toku Eyes, Big Vision, TearLab and Pr3vent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based solutions for the diagnosis of retinal diseases
|
|
| domain | founded_year | HQ Location |
AI-powered retinal images are analyzed for early disease detection.
|
|
| domain | founded_year | HQ Location |
Multi-platform systems for ophthalmic diagnosis and analysis are provided.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic tests for detecting hyperosmolarity
|
|
| domain | founded_year | HQ Location |
AI-based platform for newborn ophthalmic condition screening is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biolight
Frequently Asked Questions about BioLight
When was BioLight founded?
BioLight was founded in 2005.
Where is BioLight located?
BioLight is headquartered in Tel Aviv, Israel.
Who is the current CEO of BioLight?
Suzana Nahum Zilberberg is the current CEO of BioLight.
How many employees does BioLight have?
As of Dec 31, 2024, the latest employee count at BioLight is 4.
What is the annual revenue of BioLight?
Annual revenue of BioLight is $60.06K as on Dec 31, 2024.
What does BioLight do?
BioLight is focused on the discovery, development and commercialization of products that address ophthalmic conditions such as glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD. The company current portfolio is held through its wholly owned subsidiary XLVision, and includes Eye-D (an in-office insertable platform that provides for controlled release of ophthalmic medications over time), IOPtiMate (a surgical system that enables a non-penetrating, CO2 laser-assisted procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery) to reduce elevated IOP), TeaRx ( a diagnostic solution that provides a multi-parameter, objective, rapid, simple, semi-quantitative analysis of tear film in order to identify one or more underlying causes of DES), and OphRx (a non-invasive topical drug delivery technology). BioLight also owns 46 of Micromedic Inc.
Who are the top competitors of BioLight?
BioLight's top competitors include Retinai Medical, Toku Eyes and Pr3vent.
Is BioLight publicly traded?
Yes, BioLight is publicly traded on TASE under the ticker symbol BOLT.
What is BioLight's ticker symbol?
The ticker symbol of BioLight is BOLT on TASE.